Suheil Albert Atallah-Yunes

16PUBLICATIONS
78CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCancer diagnosisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|May 10, 2026
Predictors of renal response in AL amyloidosis following anti-plasma cell therapy: The impact of baseline serum free light chain levels and light chain isotype.

|Apr 21, 2026
Lymphocyte dynamics after CAR-T therapy for non-Hodgkin lymphoma.

|Oct 16, 2025
EBV+ polymorphic B-cell lymphoproliferative disorder, NOS: a single-center study of a newly recognized pathologic entity.

Suheil Albert Atallah-Yunes, Thomas M Habermann, Matthew J Rees

|Sep 29, 2025
Impact of residual clonal plasma cells in S-phase at the time of autologous stem cell transplantation on clinical outcomes.

Tamer Hellou, Daniel G Packard, Suheil Albert Atallah-Yunes

|Sep 03, 2025
Multi-Institutional Study of ALK-Positive Large B-Cell Lymphoma: Outcomes in the Era of ALK Inhibitors and Biologically Informed Therapies.

Suheil Albert Atallah-Yunes, Chijioke C Nze, Rebecca L King

|Aug 14, 2025
Non-DLBCL monomorphic and Hodgkin lymphoma PTLD: clinical insights and treatment strategies.

Suheil Albert Atallah-Yunes, Arushi Khurana, Thomas M Habermann

Pageof 3

Frequent Collaborators

7 joint publications

Yucai Wang

6 joint publications

Thomas M Habermann

4 joint publications

Stephen M Ansell

4 joint publications

Matthew J Rees